Potential benefits of the irreversible pan-erbB inhibitor, CI-1033, in the treatment of breast cancer

Publisher Website

30 June 2002

journal article
Published by Elsevier in Seminars in Oncology

Vol. 29 (3) , 11-21
https://doi.org/10.1016/s0093-7754(02)70122-x

Abstract

No abstract available

Keywords

Cited by 18 articles